- Home
- FOXO vs TNON Comparison
FOXO vs TNON Comparison
Compare FOXO & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXO
- TNON
- Stock Information
- Founded
- FOXO 2019
- TNON 2012
- Country
- FOXO United States
- TNON United States
- Employees
- FOXO N/A
- TNON N/A
- Industry
- FOXO Retail: Computer Software & Peripheral Equipment
- TNON Medical Specialities
- Sector
- FOXO Technology
- TNON Health Care
- Exchange
- FOXO Nasdaq
- TNON Nasdaq
- Market Cap
- FOXO 2.4M
- TNON 2.2M
- IPO Year
- FOXO N/A
- TNON 2022
- Fundamental
- Price
- FOXO $0.53
- TNON $2.54
- Analyst Decision
- FOXO
- TNON Strong Buy
- Analyst Count
- FOXO 0
- TNON 2
- Target Price
- FOXO N/A
- TNON $16.00
- AVG Volume (30 Days)
- FOXO 143.7M
- TNON 1.4M
- Earning Date
- FOXO 08-19-2024
- TNON 11-13-2024
- Dividend Yield
- FOXO N/A
- TNON N/A
- EPS Growth
- FOXO N/A
- TNON N/A
- EPS
- FOXO N/A
- TNON N/A
- Revenue
- FOXO $1,341,000.00
- TNON $3,315,000.00
- Revenue This Year
- FOXO N/A
- TNON $51.09
- Revenue Next Year
- FOXO N/A
- TNON $88.88
- P/E Ratio
- FOXO N/A
- TNON N/A
- Revenue Growth
- FOXO N/A
- TNON 38.30
- 52 Week Low
- FOXO $0.13
- TNON $2.40
- 52 Week High
- FOXO $1.30
- TNON $20.00
- Technical
- Relative Strength Index (RSI)
- FOXO 52.56
- TNON 33.93
- Support Level
- FOXO $0.55
- TNON $2.40
- Resistance Level
- FOXO $0.84
- TNON $2.66
- Average True Range (ATR)
- FOXO 0.27
- TNON 0.20
- MACD
- FOXO -0.01
- TNON -0.06
- Stochastic Oscillator
- FOXO 33.61
- TNON 11.67
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.